1. The non-therapeutic use of steroids is dangerous. Meanwhile, the use of MAP™ has been shown to be safe.
2. The increase in muscle mass achieved by using steroids is temporary. Once the use of steroids is stopped, the previously acquired muscle mass is lost. On the contrary, the muscle mass gained by using MAP™ may be permanent, even if its use is interrupted.
3. The use of steroids causes an increased water and sodium retention in the interstitial compartment (the space surrounding muscle cells). As a result, muscle volume increases while muscle density decreases. On the contrary, the use of MAP™ may normalize water and sodium retention. As a result, muscle density may optimize. Therefore, the acquired muscle volume is not due to water retention but to a measurable increase in muscle mass and strength.
The results of comparative, double-blind, triple- and quintuple-crossover Net Nitrogen Utilization (NNU) clinical studies have shown that the subjects, while taking MAP™, as a dietary protein substitute, achieved a body’s 99% NNU. This means that 99% of MAP’s constituent amino acids followed the anabolic pathway, thus acting as precursor of body’s protein synthesis. By comparison, the most nutritious dietary proteins provide an average of only 32% NNU. Hence, MAP™ is more nutritious than dietary proteins. This has been confirmed by the fact that during the studies, each subject body’s nitrogen balance was maintained in equilibrium by taking MAP™ as a sole and total substitute of dietary proteins in a dosage of only 400 mg/kg/day (ideal weight) which provided less than 2 kcal/day ( 1 g MAP™ = 0.04 kcal). The studies results have also shown that 1% of MAP’s constituent amino acids followed the catabolic pathway, thus releasing only 1% of nitrogen catabolites and energy. By comparison dietary proteins release an average of 68% nitrogen catabolites and energy. These facts evidence that MAP™ is safer than dietary proteins and provides the lowest amount of energy in comparison to any dietary protein.